FDA Approved: DIFLUPREDNATE — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Alembic Pharmaceuticals' difluprednate ophthalmic emulsion 0.05% as a generic version for treating inflammation of the eye and post-operative infla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation of the Eye
• Postoperative Inflammation

Drugs mentioned

• Difluprednate ophthalmic (Difluprednate)

Snippet

ORIG AP for DIFLUPREDNATE (DIFLUPREDNATE OPHTHALMIC)